TipRanks on MSN

Wave Life Sciences announces positive phase 1 trial results

An update from Wave Life Sciences ( ($WVE) ) is now available. On December 8, 2025, Wave Life Sciences announced positive interim data from its ...
BioSpace

Wave Soars on Early Results for Obesity Treatment That Could ‘Disrupt’ the Landscape

Although still in Phase I, Wave Life Sciences’ injectable RNA weight loss treatment achieved results that impressed analysts, ...
Fierce Biotech

Wave, Structure stocks double on obesity data readouts

Amid an outpouring of obesity data Monday, Wave Life Sciences and Structure Therapeutics were among the biotechs jockeying to ...
The Manila Times

Wave Life Sciences to Announce Interim Data from the Phase 1 INLIGHT Trial of WVE-007 (INHBE) for Obesity on Monday, December 8, 2025

Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA ...
Seeking Alpha

First Wave BioPharma Engages Rho to Manage Phase 2 Clinical Trial of Enhanced Adrulipase Formulation

BOCA RATON, Fla., Oct. 31, 2022 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc. (FWBI) (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in the ...
Business Insider

Wave Life Sciences Provides Update on Phase 1b/2a PRECISION-HD Trials

Wave expects to initiate dosing in a Phase 1b/2a clinical trial for WVE-003 in 2021. As people with HD can carry multiple SNPs, participants from the PRECISON-HD trials will be offered the opportunity ...